Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line

Anna Kreutzman; Bhagwan Yadav; Tim H. Brummendorf; Bjorn Tore Gjertsen; Moon Hee Lee; Jeroen Janssen; Tiina Kasanen; Perttu Koskenvesa; Kourosh Lotfi; Berit Markevärn; Ulla Olsson-Stromberg; Jesper Stentoft; Leif Stenke; Stina Söderlund; Lene Udby; Johan Richter; Henrik Hjörth-Hansen; Satu Mustjoki

doi:10.1080/2162402X.2019.1638210

Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line

Anna Kreutzman, Bhagwan Yadav, Tim H. Brummendorf, Bjorn Tore Gjertsen, Moon Hee Lee, Jeroen Janssen, Tiina Kasanen, Perttu Koskenvesa, Kourosh Lotfi, Berit Markevärn, Ulla Olsson-Stromberg, Jesper Stentoft, Leif Stenke, Stina Söderlund, Lene Udby, Johan Richter, Henrik Hjörth-Hansen, Satu Mustjoki

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Artikelnummer	e1638210
Tidskrift	OncoImmunology
Volym	8
Utgåva	9
Antal sidor	13
ISSN	2162-402X
DOI	https://doi.org/10.1080/2162402X.2019.1638210
Status	Publicerad - 2 sep 2019
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3122 Cancersjukdomar

Åtkomst av dokument

10.1080/2162402X.2019.1638210

Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first lineSlutlig publicerad version, 6,05 MBLicens: CC BY-NC-ND

Citera det här

Kreutzman, A., Yadav, B., Brummendorf, T. H., Gjertsen, B. T., Lee, M. H., Janssen, J., Kasanen, T., Koskenvesa, P., Lotfi, K., Markevärn, B., Olsson-Stromberg, U., Stentoft, J., Stenke, L., Söderlund, S., Udby, L., Richter, J., Hjörth-Hansen, H., & Mustjoki, S. (2019). Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line. OncoImmunology, 8(9), [e1638210]. https://doi.org/10.1080/2162402X.2019.1638210

Kreutzman, Anna ; Yadav, Bhagwan ; Brummendorf, Tim H. ; Gjertsen, Bjorn Tore ; Lee, Moon Hee ; Janssen, Jeroen ; Kasanen, Tiina ; Koskenvesa, Perttu ; Lotfi, Kourosh ; Markevärn, Berit ; Olsson-Stromberg, Ulla ; Stentoft, Jesper ; Stenke, Leif ; Söderlund, Stina ; Udby, Lene ; Richter, Johan ; Hjörth-Hansen, Henrik ; Mustjoki, Satu. / Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line. I: OncoImmunology. 2019 ; Vol. 8, Nr. 9.

@article{af86e28ac19c47a39effbd1b5c44ed9d,

title = "Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line",

keywords = "CML, imatinib, bosutinib, Sokal, BCR-ABL, CHRONIC MYELOID-LEUKEMIA, NK-CELLS, INHIBITORS IMATINIB, T-CELLS, NILOTINIB, DASATINIB, DISCONTINUATION, MANAGEMENT, MONOCYTES, RESPONSES, 3122 Cancers",

author = "Anna Kreutzman and Bhagwan Yadav and Brummendorf, {Tim H.} and Gjertsen, {Bjorn Tore} and Lee, {Moon Hee} and Jeroen Janssen and Tiina Kasanen and Perttu Koskenvesa and Kourosh Lotfi and Berit Markev{\"a}rn and Ulla Olsson-Stromberg and Jesper Stentoft and Leif Stenke and Stina S{\"o}derlund and Lene Udby and Johan Richter and Henrik Hj{\"o}rth-Hansen and Satu Mustjoki",

year = "2019",

month = sep,

day = "2",

doi = "10.1080/2162402X.2019.1638210",

language = "English",

volume = "8",

journal = "OncoImmunology",

issn = "2162-4011",

publisher = "TAYLOR & FRANCIS INC",

number = "9",

}

Kreutzman, A , Yadav, B, Brummendorf, TH, Gjertsen, BT, Lee, MH, Janssen, J, Kasanen, T, Koskenvesa, P, Lotfi, K, Markevärn, B, Olsson-Stromberg, U, Stentoft, J, Stenke, L, Söderlund, S, Udby, L, Richter, J, Hjörth-Hansen, H & Mustjoki, S 2019, 'Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line', OncoImmunology, vol. 8, nr. 9, e1638210. https://doi.org/10.1080/2162402X.2019.1638210

Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line. / Kreutzman, Anna ; Yadav, Bhagwan; Brummendorf, Tim H.; Gjertsen, Bjorn Tore; Lee, Moon Hee; Janssen, Jeroen; Kasanen, Tiina; Koskenvesa, Perttu; Lotfi, Kourosh; Markevärn, Berit; Olsson-Stromberg, Ulla; Stentoft, Jesper; Stenke, Leif; Söderlund, Stina; Udby, Lene; Richter, Johan; Hjörth-Hansen, Henrik; Mustjoki, Satu.

I: OncoImmunology, Vol. 8, Nr. 9, e1638210, 02.09.2019.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

TY - JOUR

T1 - Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line

AU - Kreutzman, Anna

AU - Yadav, Bhagwan

AU - Brummendorf, Tim H.

AU - Gjertsen, Bjorn Tore

AU - Lee, Moon Hee

AU - Janssen, Jeroen

AU - Kasanen, Tiina

AU - Koskenvesa, Perttu

AU - Lotfi, Kourosh

AU - Markevärn, Berit

AU - Olsson-Stromberg, Ulla

AU - Stentoft, Jesper

AU - Stenke, Leif

AU - Söderlund, Stina

AU - Udby, Lene

AU - Richter, Johan

AU - Hjörth-Hansen, Henrik

AU - Mustjoki, Satu

PY - 2019/9/2

Y1 - 2019/9/2

KW - CML

KW - imatinib

KW - bosutinib

KW - Sokal

KW - BCR-ABL

KW - CHRONIC MYELOID-LEUKEMIA

KW - NK-CELLS

KW - INHIBITORS IMATINIB

KW - T-CELLS

KW - NILOTINIB

KW - DASATINIB

KW - DISCONTINUATION

KW - MANAGEMENT

KW - MONOCYTES

KW - RESPONSES

KW - 3122 Cancers

U2 - 10.1080/2162402X.2019.1638210

DO - 10.1080/2162402X.2019.1638210

M3 - Article

VL - 8

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 9

M1 - e1638210

ER -